Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CRHBP | P24387 | 1/20 | 0.39 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.39 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.39 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.39 |
| ▸ | PABPC1 | P11940 | 2/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | CASP1 | P29466 | 1/20 | 0.32 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11955188 | 0.87 | — | — | |
| SCHEMBL12317659 | 0.86 | — | — | |
| SCHEMBL14682175 | 0.81 | — | — | |
| SCHEMBL12227462 | 0.80 | CYP1A2 (0.41) | ALDH1A1HPGDTSHRHSD17B10L3MBTL1 | |
| SCHEMBL14682140 | 0.80 | — | — | |
| SCHEMBL10046440 | 0.80 | ALDH1A1 (0.32) | KDM4EMAPTALDH1A1MAPK1 | |
| SCHEMBL29709221 | 0.79 | KEAP1 (0.46) | CRHBPCRHR2KEAP1NFE2L2PABPC1 | |
| SCHEMBL30040842 | 0.79 | KEAP1 (0.46) | CRHBPCRHR2KEAP1NFE2L2PABPC1 | |
| SCHEMBL961673 | 0.79 | KEAP1 (0.46) | CRHBPCRHR2KEAP1NFE2L2PABPC1 | |
| SCHEMBL13855744 | 0.79 | ALDH1A1 (0.38) | KDM4EMAPTALDH1A1HPGDTSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130001542-A1 | ORGANIC LIGHT-EMITTING DEVICE | CANON KABUSHIKI KAISHA (JP) | 2013-01-03 | — | — | US | disclosed |
| WO-2012098793-A1 | ORGANIC COMPOUND, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND IMAGE DISPLAY DEVICE | CANON KABUSHIKI KAISHA (JP) | 2012-07-26 | — | — | WO | disclosed |
| US-20100123390-A1 | LIGHT-EMITTING DEVICE, IMAGE DISPLAY APPARATUS, AND NOVEL ORGANIC COMPOUND | CANON KABUSHIKI KAISHA (JP) | 2010-05-20 | — | — | US | disclosed |
| US-20080199726-A1 | Electroluminescent Device | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2008-08-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100123390-A1 | LIGHT-EMITTING DEVICE, IMAGE DISPLAY APPARATUS, AND NOVEL ORGANIC COMPOUND | OCIAD1, OCIAD2, OR51E2 | CRHBP 4221/4885CRHR2 3968/4885KEAP1 2356/4885 |
| US-20080199726-A1 | Electroluminescent Device | TPMT, THPO, KYNU | CRHBP 3743/4885CRHR2 3907/4885KEAP1 2572/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.